<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>创新的通用流感疫苗在首次临床试验中显示出希望 Innovative universal flu vaccine shows promise in first clinical test</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Innovative universal flu vaccine shows promise in first clinical test<br/>创新的通用流感疫苗在首次临床试验中显示出希望 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-12-08 12:59:08</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/12/ff2039d190a61dfeda9cd6d1b4b15053.jpg"><img src="http://img2.diglog.com/img/2020/12/ff2039d190a61dfeda9cd6d1b4b15053.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>For epidemiologists, the COVID-19 pandemic has greatly intensified their long-standing nightmare about another virus: the emergence of a new and deadly strain of flu. A universal flu vaccine, effective against any strain of the influenza virus that can infect humans, could protect us from this peril, but progress has been slow. A novel concept for one universal vaccine candidate has now passed its first test in a small clinical trial, its  developers report today in  Nature Medicine.</p><p>对于流行病学家来说，COVID-19大流行极大地加剧了他们长期以来对另一种病毒的噩梦：一种新的致命流感病毒的出现。通用流感疫苗可有效抵抗任何可能感染人类的​​流感病毒株，可以保护我们免受这种危害，但进展缓慢。开发人员今天在《自然医学》上报告说，针对一种通用疫苗候选物的新颖概念现已通过一项小型临床试验通过了首次测试。</p><p> “This is an important paper,” says Aubree Gordon, an epidemiologist at the University of Michigan School of Public Health who studies influenza transmission and vaccines.</p><p> “这是重要的论文，”密歇根大学公共卫生学院的流行病学家奥布里·戈登说，他研究流感的传播和疫苗。</p><p> The influenza virus rapidly accumulates mutations and easily “reassorts,” or swaps, genes between strains, creating variants that can dodge any past immunity people had acquired naturally or from vaccines. That’s why a new flu vaccine must be developed each year.</p><p> 流感病毒会迅速积累突变，并容易在菌株之间“重新排列”或交换基因，从而产生可以躲避人们过去自然或从疫苗获得的任何免疫力的变异体。因此，每年必须开发一种新的流感疫苗。</p><p> Existing flu vaccines contain weakened or inactivated influenza viruses with a mix of hemagglutinins (HAs), the proteins that stud their surfaces. These vaccines primarily aim to trigger antibody responses against HA’s top part, or head. Genetic changes in flu viruses rarely alter most of the head. But a small part of the head does reassort, or mutate, frequently, which allows new viral strains to dodge any immune memory and forces flu vaccinemakers to prepare new formulations each year, with updated HAs.</p><p> 现有的流感疫苗含有弱化或灭活的流感病毒以及混合了血凝素（HAs）的蛋白质，血凝素是一种散布在其表面的蛋白质。这些疫苗的主要目的是触发针对HA顶部或头部的抗体反应。流感病毒的遗传变化很少改变大部分头部。但是头部的一小部分确实会经常重新排列或突变，这使得新的病毒株可以躲避任何免疫记​​忆，并迫使流感疫苗制造商每年使用更新的HA来准备新的制剂。</p><p> HA’s bottom portion, or stalk, is less apt to vary, and epidemiological studies have shown people who have been exposed to an influenza strain and developed antibodies to the stalk can ward off a wide variety of other strains. So, the new universal flu vaccine candidate, one of a handful in development, puts HA’s stalk front and center. The study shows for the first time that “you can develop a vaccine strategy that produces stalk-reactive antibodies in humans,” says virologist Florian Krammer of the Icahn School of Medicine at Mount Sinai, who co-leads a multi-institutional universal flu vaccines consortium funded by the U.S. National Institute of Allergy and Infectious Diseases and helped develop the candidate tested in the new trial. Other clinical trials testing stalk-based universal flu vaccine candidates have yet to report data.</p><p> 医管局的底部或茎杆不太容易变化，流行病学研究表明，暴露于流感病毒株并已开发出茎杆抗体的人可以抵御多种其他菌株。因此，新的通用流感疫苗候选药物（开发中的少数药物之一）将医管局的茎放在首位。该研究首次表明“您可以开发出一种可以在人体中产生茎反应性抗体的疫苗策略，”西奈山伊坎医学院的病毒学家弗洛里安·克拉默说，他是多机构通用流感疫苗的共同负责人。由美国国家过敏和传染病研究所资助的财团，并帮助开发了在新试验中测试过的候选人。其他测试基于茎的通用流感疫苗候选药物的临床试验尚未报告数据。</p><p> Targeting the stalk is harder than it sounds, because immune memory cells built up over a lifetime of flu infections react so strongly to the conserved region of HA’s head that this response overrides production of antibodies against the stalk. Some researchers have tried to make flu vaccines that only contain HA’s stalk, but this fragment is highly unstable. To get around this problem, Krammer and colleagues made what they call chimeric HAs, which link the protein’s conserved stalk to unusual heads that are entirely new to the human immune system and don’t trigger a person’s immune memory. Only low levels of head antibodies are produced, allowing a strong new immune response to stalk to dominate. In essence, the head of the chimera is only there to stabilize the stalk.</p><p> 瞄准茎比听起来要难，因为在流感感染的一生中积累的免疫记忆细胞对HA头部的保守区域反应强烈，以至于这种反应优先于针对茎的抗体的产生。一些研究人员试图制造仅含有HA茎的流感疫苗，但是这种片段非常不稳定。为了解决这个问题，Krammer和他的同事制造了所谓的嵌合HA，将蛋白质的保守茎与不寻常的头部连接在一起，这些头部对于人类免疫系统来说是全新的，并且不会触发人的免疫记忆。仅产生低水平的头部抗体，从而使对茎的强烈新免疫反应占主导地位。本质上，嵌合体的头部仅用于稳定茎。</p><p> Influenza vaccines contain three to four strains of the virus that are classified as group A, which breaks into two other divisions, and group B strains. The researchers developed vaccines made from live, weakened versions of influenza viruses or inactivated viruses bearing chimeric HAs representing only one division of group A. In the trial, 51 participants received the various vaccines and their antibodies were compared with those of 15 people who received placebos. A single shot of vaccine with chimeric HA inactivated viruses, the researchers report, “induced remarkably high antistalk antibody titers.”</p><p> 流感疫苗包含三到四个病毒株，分为A组（分为两个部分）和B组。研究人员开发了由活的，弱毒的流感病毒或带有嵌合HA的灭活病毒制成的疫苗，这些嵌合HA仅代表A组的一个部门。在试验中，有51名参与者接受了各种疫苗，并将其抗体与接受安慰剂的15人进行了比较。研究人员报告说，带有嵌合HA灭活病毒的疫苗单次注射“诱导了很高的抗茎抗体滴度”。 </p><p> The trial was only a phase I study to establish safety and measure immune responses, which means it didn’t test the ability of the vaccines to protect people from influenza. Still, when the researchers transferred human antibodies triggered by the experimental vaccines into mice and then “challenged” the rodents with the influenza virus, the mice lost far less weight than untreated mice who also were infected, suggesting the antibodies protected them. Immunologist James Crowe, who runs the vaccine center at Vanderbilt University, says the study is “a serious effort” to test the stalk antibody hypothesis and “an important first step.”</p><p>该试验只是建立安全性和测量免疫反应的第一阶段研究，这意味着它并未测试疫苗保护人们免受流感侵袭的能力。尽管如此，当研究人员将实验疫苗触发的人类抗体转移到小鼠体内，然后用流感病毒“攻击”啮齿动物时，小鼠的体重减轻的幅度远小于未感染小鼠的体重，这表明抗体可以保护它们。范德比尔特大学疫苗中心的免疫学家詹姆斯·克罗（James Crowe）说，这项研究是“认真的努力”，旨在检验茎杆抗体的假设，并且是“重要的第一步”。</p><p> Krammer says it will likely take at least 2 years to develop chimeric HAs representing enough other strains from influenza groups A and B to be combined into a universal vaccine. That mix would then be tested in a large-scale, multiyear study designed to show that the vaccine candidate works better than the seasonal vaccine. The seasonal vaccine works fairly well in years when its HA closely matches the variants in circulation, so the chimeric HAs would only show their true power during one of the rarer years when there’s a mismatch.</p><p> Krammer说，可能需要至少2年的时间才能开发出嵌合的HA，它们代表了来自甲型和乙型流感的足够多其他菌株，可以组合成通用疫苗。然后将在一项大规模的多年研究中对该混合物进行测试，该研究旨在证明该候选疫苗比季节性疫苗更有效。季节性疫苗在其HA与流通中的变体非常匹配的年份中效果很好，因此嵌合HA仅在出现不匹配的罕见年份之一中才显示其真实能力。</p><p> This “long development path,” Krammer suspects, is the main reason his team lost an initial corporate partner, GlaxoSmithKline, which has another universal flu vaccine in clinical trials. “It’s difficult to get to get a lot of interest for something like this,” Krammer says.</p><p> Krammer怀疑，这条“漫长的发展道路”是他的团队失去最初的公司合作伙伴GlaxoSmithKline的主要原因，该公司在临床试验中使用了另一种通用流感疫苗。克拉默说：“很难获得像这样的东西的浓厚兴趣。” </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.sciencemag.org/news/2020/12/innovative-universal-flu-vaccine-shows-promises-it-first-clinical-test">https://www.sciencemag.org/news/2020/12/innovative-universal-flu-vaccine-shows-promises-it-first-clinical-test</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/通用/">#通用</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/universal/">#universal</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>